2C-TFM
| Clinical data | |
|---|---|
| Other names | 2C-CF3; 2,5-Dimethoxy-4-trifluoromethylphenethylamine; 4-Trifluoromethyl-2,5-dimethoxyphenethylamine |
| Routes of administration | Oral |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Pharmacokinetic data | |
| Duration of action | ≥5–10 hours[1][2] |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H14F3NO2 |
| Molar mass | 249.233 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 260 °C (500 °F) (hydrochloride)[3] |
SMILES
| |
InChI
| |
| (verify) | |
2C-TFM, also known as 4-trifluoromethyl-2,5-dimethoxyphenethylamine, is a serotonin 5-HT2 receptor agonist and psychedelic drug of the phenethylamine and 2C families.[1][2] It has also been called 2C-CF3, a name derived from the para-trifluoromethyl group it contains. The drug was first synthesized in the laboratory of David E. Nichols. Later, it was tried humans and its psychedelic effects were confirmed.[1] 2C-TFM is the most potent psychedelic of the 2C psychedelics, with an active dosage of 3 to 6 mg orally.[1][2]
- ^ a b c d Cite error: The named reference
Trachsel2012was invoked but never defined (see the help page). - ^ a b c Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226.
- ^ Cite error: The named reference
Nicholswas invoked but never defined (see the help page).